Uso de Corticoides en COVID-19 y posibles daños de su inadecuada prescripción / Use of Corticosteroids in COVID-19 and possible damages of its inadequate prescription
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo
; 14(Supl. 1): 81-83, oct. 21, 2021.
Article
in Es, En
|
LILACS-Express
| LILACS
| ID: biblio-1354873
Responsible library:
PE386.9
RESUMEN
La infección por COVID-19 es un grave problema de salud pública en el Perú. Uno de los medicamentos del cual tenemos evidencia clara de su uso en COVID-19 son los corticoesteroides;sonfármacoslipofílicosdeacciónnuclear.Seindicanen enfermedades inflamatorias y autoinmunes en donde el propio sistema inmune ataca las células de nuestro organismo
ABSTRACT
COVID-19 infection is a serious public health problem in Peru. One of the drugs for which we have clear evidence of their use in COVID-19 is corticosteroids; these are lipophilic, nuclear-acting drugs that are indicated in inflammatory and autoimmune diseases where the immune system itself attacks the cells of our organism the cells of our organism the cells of our body the cells of our body the cells of our body the cells of our body the cells of our body the cells of our body.
Full text:
1
Index:
LILACS
Language:
En
/
Es
Journal:
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo
Journal subject:
MEDICINA
Year:
2021
Type:
Article